{
    "title": "Allergan says it stands by statements on Valeant",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2801809/Allergan-says-stands-statements-Valeant.html",
    "date": "2014-10-21",
    "keywords": [
        "court",
        "valeant",
        "business",
        "board",
        "allergan",
        "square",
        "october",
        "hedge",
        "fund",
        "officer",
        "campaign",
        "ackman",
        "deal",
        "insider",
        "trading",
        "santa",
        "pyott",
        "harvard",
        "et",
        "al",
        "district",
        "gmt",
        "email",
        "herbstbaylissboston",
        "inc",
        "tuesday",
        "evidence",
        "capital",
        "management",
        "unsustainability",
        "opportunity",
        "hearing",
        "model",
        "time",
        "company",
        "statementpershing",
        "billionaire",
        "william",
        "drugmaker",
        "dealallergan",
        "try",
        "ceo",
        "david",
        "departure",
        "jeff",
        "pressure",
        "market",
        "accounting",
        "advisor",
        "goldman",
        "sachs",
        "wellpaying",
        "expense",
        "truth",
        "stock",
        "price",
        "transactionmost",
        "filing",
        "monday",
        "struck",
        "information",
        "month",
        "companys",
        "pyottackman",
        "dec",
        "meeting",
        "slate",
        "takeoverlast",
        "week",
        "review",
        "undergraduate",
        "journal",
        "math",
        "correctionthe",
        "case",
        "v",
        "california",
        "division",
        "reporting",
        "editing",
        "franklin",
        "paul",
        "von",
        "ahn"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}